103 related articles for article (PubMed ID: 9506540)
1. Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells.
Blagosklonny MV; El-Deiry WS
Int J Cancer; 1998 Mar; 75(6):933-40. PubMed ID: 9506540
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells.
Horio Y; Hasegawa Y; Sekido Y; Takahashi M; Roth JA; Shimokata K
Cancer Gene Ther; 2000 Apr; 7(4):537-44. PubMed ID: 10811471
[TBL] [Abstract][Full Text] [Related]
3. Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells.
Blagosklonny MV; Giannakakou P; Wojtowicz M; Romanova LY; Ain KB; Bates SE; Fojo T
J Clin Endocrinol Metab; 1998 Jul; 83(7):2516-22. PubMed ID: 9661637
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
5. Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung cancer cells.
Osaki S; Nakanishi Y; Takayama K; Pei XH; Ueno H; Hara N
Cancer Gene Ther; 2000 Feb; 7(2):300-7. PubMed ID: 10770640
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug.
Blagosklonny MV; el-Deiry WS
Int J Cancer; 1996 Jul; 67(3):386-92. PubMed ID: 8707413
[TBL] [Abstract][Full Text] [Related]
7. The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines.
Eisold S; Linnebacher M; Ryschich E; Antolovic D; Hinz U; Klar E; Schmidt J
World J Gastroenterol; 2004 Dec; 10(24):3583-9. PubMed ID: 15534911
[TBL] [Abstract][Full Text] [Related]
8. The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines.
Yamamoto M; Maehara Y; Oda S; Ichiyoshi Y; Kusumoto T; Sugimachi K
Cancer Chemother Pharmacol; 1999; 43(1):43-9. PubMed ID: 9923540
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
[TBL] [Abstract][Full Text] [Related]
10. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer.
Gurnani M; Lipari P; Dell J; Shi B; Nielsen LL
Cancer Chemother Pharmacol; 1999; 44(2):143-51. PubMed ID: 10412949
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo.
Nagayama Y; Yokoi H; Takeda K; Hasegawa M; Nishihara E; Namba H; Yamashita S; Niwa M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4081-6. PubMed ID: 11095436
[TBL] [Abstract][Full Text] [Related]
14. Selective sensitization to DNA-damaging agents in a human rhabdomyosarcoma cell line with inducible wild-type p53 overexpression.
Gibson AA; Harwood FG; Tillman DM; Houghton JA
Clin Cancer Res; 1998 Jan; 4(1):145-52. PubMed ID: 9516963
[TBL] [Abstract][Full Text] [Related]
15. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
Meng RD; Phillips P; El-Deiry WS
Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
[TBL] [Abstract][Full Text] [Related]
16. Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent.
Ogawa N; Fujiwara T; Kagawa S; Nishizaki M; Morimoto Y; Tanida T; Hizuta A; Yasuda T; Roth JA; Tanaka N
Int J Cancer; 1997 Nov; 73(3):367-70. PubMed ID: 9359484
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.
Guan B; Yue P; Clayman GL; Sun SY
J Cell Physiol; 2001 Jul; 188(1):98-105. PubMed ID: 11382926
[TBL] [Abstract][Full Text] [Related]
18. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.
Kano M; Matsushita K; Rahmutulla B; Yamada S; Shimada H; Kubo S; Hiwasa T; Matsubara H; Nomura F
Gene Ther; 2016 Jan; 23(1):50-6. PubMed ID: 26241176
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
